LAMB2 and Hepatic fibrosis: It was reported that LAMs deficiency in the liver can aggravate liver inflammation and fibrosis induced by nonalcoholic steatohepatitis (NASH) in mice, indicating that LAMs can inhibit the progression of inflammation and liver fibrosis (49, 52).